Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 47 | 2020 | 1794 | 2.530 |
Why?
|
Lung | 71 | 2024 | 3664 | 2.080 |
Why?
|
Lung Diseases, Interstitial | 23 | 2020 | 464 | 1.480 |
Why?
|
Pulmonary Artery | 23 | 2020 | 1063 | 1.420 |
Why?
|
Idiopathic Pulmonary Fibrosis | 11 | 2023 | 451 | 1.160 |
Why?
|
Pneumoconiosis | 5 | 2024 | 12 | 1.140 |
Why?
|
Occupational Exposure | 6 | 2024 | 277 | 1.130 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 11 | 2023 | 1137 | 1.090 |
Why?
|
Lung Diseases | 10 | 2023 | 718 | 1.050 |
Why?
|
Emphysema | 5 | 2022 | 123 | 1.050 |
Why?
|
Bronchiolitis | 4 | 2022 | 83 | 1.050 |
Why?
|
Coal Mining | 4 | 2024 | 9 | 0.920 |
Why?
|
Pulmonary Fibrosis | 10 | 2013 | 303 | 0.700 |
Why?
|
Familial Primary Pulmonary Hypertension | 4 | 2016 | 193 | 0.680 |
Why?
|
Alveolitis, Extrinsic Allergic | 4 | 2020 | 83 | 0.650 |
Why?
|
Neovascularization, Pathologic | 7 | 2019 | 287 | 0.580 |
Why?
|
Lung Neoplasms | 8 | 2020 | 2220 | 0.580 |
Why?
|
Bronchi | 3 | 2016 | 242 | 0.560 |
Why?
|
Bronchial Arteries | 1 | 2016 | 11 | 0.560 |
Why?
|
Veins | 2 | 2016 | 60 | 0.560 |
Why?
|
Endothelial Cells | 13 | 2020 | 732 | 0.550 |
Why?
|
Microvessels | 1 | 2016 | 77 | 0.530 |
Why?
|
Apoptosis | 19 | 2020 | 2484 | 0.520 |
Why?
|
Herpesviridae Infections | 6 | 2015 | 142 | 0.510 |
Why?
|
Military Personnel | 1 | 2022 | 529 | 0.500 |
Why?
|
Humans | 131 | 2024 | 118972 | 0.490 |
Why?
|
Models, Biological | 3 | 2020 | 1715 | 0.460 |
Why?
|
Immunohistochemistry | 22 | 2019 | 1691 | 0.450 |
Why?
|
Fibroblasts | 9 | 2017 | 842 | 0.430 |
Why?
|
Mucin-5B | 4 | 2019 | 175 | 0.420 |
Why?
|
Common Variable Immunodeficiency | 4 | 2020 | 27 | 0.390 |
Why?
|
Middle Aged | 55 | 2020 | 27617 | 0.380 |
Why?
|
Tomography, X-Ray Computed | 16 | 2023 | 2436 | 0.380 |
Why?
|
Cysts | 2 | 2023 | 93 | 0.380 |
Why?
|
Hypoxia | 8 | 2020 | 963 | 0.360 |
Why?
|
Animals | 50 | 2023 | 33381 | 0.360 |
Why?
|
Herpesvirus 8, Human | 3 | 2005 | 68 | 0.350 |
Why?
|
Bleomycin | 4 | 2019 | 228 | 0.350 |
Why?
|
Occupational Diseases | 2 | 2023 | 136 | 0.350 |
Why?
|
Immunosuppressive Agents | 5 | 2020 | 681 | 0.340 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 9 | 2013 | 103 | 0.340 |
Why?
|
Pulmonary Alveoli | 4 | 2010 | 384 | 0.340 |
Why?
|
Male | 72 | 2020 | 57801 | 0.340 |
Why?
|
Virus Diseases | 1 | 2011 | 198 | 0.330 |
Why?
|
Endothelium, Vascular | 10 | 2012 | 907 | 0.330 |
Why?
|
Gammaherpesvirinae | 3 | 2018 | 39 | 0.330 |
Why?
|
Female | 70 | 2021 | 61564 | 0.330 |
Why?
|
Endothelium | 4 | 2006 | 120 | 0.330 |
Why?
|
Disease Models, Animal | 15 | 2023 | 3730 | 0.310 |
Why?
|
Adult | 45 | 2021 | 31512 | 0.310 |
Why?
|
Biopsy | 15 | 2021 | 1079 | 0.300 |
Why?
|
Lung Transplantation | 3 | 2022 | 263 | 0.300 |
Why?
|
Rats | 20 | 2020 | 5392 | 0.300 |
Why?
|
Aged | 38 | 2020 | 19657 | 0.300 |
Why?
|
Caveolin 1 | 2 | 2006 | 23 | 0.300 |
Why?
|
Arterial Occlusive Diseases | 2 | 2020 | 74 | 0.290 |
Why?
|
Gene Expression Regulation | 8 | 2017 | 2445 | 0.290 |
Why?
|
Caveolin 2 | 1 | 2006 | 4 | 0.280 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2006 | 20 | 0.280 |
Why?
|
Pulmonary Emphysema | 4 | 2013 | 327 | 0.280 |
Why?
|
Silicosis | 2 | 2023 | 21 | 0.270 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2006 | 56 | 0.270 |
Why?
|
Neoplasm Proteins | 2 | 2020 | 401 | 0.260 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 289 | 0.260 |
Why?
|
Environmental Exposure | 1 | 2009 | 405 | 0.260 |
Why?
|
Respiratory Function Tests | 11 | 2020 | 526 | 0.260 |
Why?
|
Pyrroles | 6 | 2014 | 191 | 0.250 |
Why?
|
Tissue Banks | 1 | 2004 | 19 | 0.240 |
Why?
|
Vascular Endothelial Growth Factor A | 13 | 2013 | 527 | 0.240 |
Why?
|
Rats, Sprague-Dawley | 13 | 2020 | 2478 | 0.240 |
Why?
|
Gene Expression | 6 | 2020 | 1489 | 0.240 |
Why?
|
Macrophages, Alveolar | 5 | 2018 | 359 | 0.240 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2023 | 23 | 0.240 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2015 | 246 | 0.230 |
Why?
|
Birt-Hogg-Dube Syndrome | 1 | 2023 | 6 | 0.230 |
Why?
|
Mice | 25 | 2023 | 15520 | 0.230 |
Why?
|
Diagnosis, Differential | 9 | 2023 | 1384 | 0.230 |
Why?
|
Coal | 4 | 2024 | 15 | 0.230 |
Why?
|
Indoles | 6 | 2014 | 316 | 0.230 |
Why?
|
Bronchiolitis Obliterans | 2 | 2022 | 66 | 0.230 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2023 | 23 | 0.230 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2023 | 35 | 0.220 |
Why?
|
Mycobacterium Infections | 1 | 2023 | 61 | 0.220 |
Why?
|
Anthracosis | 1 | 2022 | 3 | 0.220 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2017 | 1171 | 0.220 |
Why?
|
Dust | 4 | 2024 | 88 | 0.220 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2022 | 16 | 0.220 |
Why?
|
Interferon-gamma | 5 | 2013 | 736 | 0.220 |
Why?
|
Neprilysin | 3 | 2010 | 48 | 0.220 |
Why?
|
Silicon Dioxide | 4 | 2024 | 95 | 0.220 |
Why?
|
Severity of Illness Index | 9 | 2017 | 2674 | 0.210 |
Why?
|
Rhinitis | 2 | 2017 | 129 | 0.210 |
Why?
|
Skull Base Neoplasms | 1 | 2022 | 29 | 0.210 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 3 | 2008 | 98 | 0.210 |
Why?
|
Mycobacterium | 1 | 2023 | 103 | 0.210 |
Why?
|
RNA, Messenger | 5 | 2019 | 2657 | 0.210 |
Why?
|
Sinusitis | 2 | 2017 | 175 | 0.200 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2003 | 72 | 0.200 |
Why?
|
Pulmonary Eosinophilia | 1 | 2021 | 25 | 0.200 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 1597 | 0.190 |
Why?
|
Autoimmune Diseases | 2 | 2019 | 398 | 0.190 |
Why?
|
Inflammation | 9 | 2022 | 2566 | 0.190 |
Why?
|
Prognosis | 8 | 2018 | 3443 | 0.190 |
Why?
|
Hodgkin Disease | 2 | 2003 | 119 | 0.190 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 216 | 0.190 |
Why?
|
Mice, Knockout | 8 | 2018 | 2680 | 0.190 |
Why?
|
Vaping | 1 | 2021 | 51 | 0.180 |
Why?
|
Inhalation Exposure | 2 | 2018 | 87 | 0.180 |
Why?
|
Myositis, Inclusion Body | 1 | 2019 | 11 | 0.180 |
Why?
|
Interleukin-18 | 3 | 2013 | 228 | 0.180 |
Why?
|
Virus Activation | 2 | 2018 | 80 | 0.170 |
Why?
|
fas Receptor | 3 | 2018 | 98 | 0.170 |
Why?
|
Nestin | 1 | 2019 | 16 | 0.170 |
Why?
|
Orthomyxoviridae Infections | 1 | 2019 | 53 | 0.170 |
Why?
|
Virus Latency | 2 | 2018 | 84 | 0.170 |
Why?
|
Chronic Disease | 7 | 2020 | 1636 | 0.170 |
Why?
|
Air Pollutants | 1 | 2023 | 316 | 0.170 |
Why?
|
Fibrosis | 5 | 2023 | 483 | 0.170 |
Why?
|
Toll-Like Receptor 3 | 1 | 2019 | 31 | 0.170 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2018 | 7 | 0.170 |
Why?
|
Racemases and Epimerases | 1 | 2018 | 11 | 0.170 |
Why?
|
Apolipoprotein A-I | 1 | 2018 | 26 | 0.170 |
Why?
|
Microcirculation | 1 | 2019 | 155 | 0.170 |
Why?
|
Immunoglobulin A | 1 | 2019 | 174 | 0.170 |
Why?
|
Cell Line | 10 | 2018 | 2707 | 0.160 |
Why?
|
Pulmonary Circulation | 4 | 2009 | 424 | 0.160 |
Why?
|
Pneumonia, Bacterial | 2 | 2018 | 110 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2020 | 64 | 0.160 |
Why?
|
Lung Injury | 1 | 2021 | 210 | 0.160 |
Why?
|
Pneumonia | 7 | 2009 | 592 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2018 | 11 | 0.160 |
Why?
|
Epoprostenol | 3 | 2012 | 132 | 0.160 |
Why?
|
Genetic Variation | 2 | 2018 | 926 | 0.160 |
Why?
|
Myocytes, Smooth Muscle | 4 | 2013 | 236 | 0.160 |
Why?
|
Down-Regulation | 2 | 2018 | 627 | 0.160 |
Why?
|
Case-Control Studies | 11 | 2018 | 3171 | 0.160 |
Why?
|
Endothelial Growth Factors | 4 | 2002 | 55 | 0.160 |
Why?
|
Cornified Envelope Proline-Rich Proteins | 1 | 2017 | 10 | 0.160 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2009 | 454 | 0.160 |
Why?
|
Lymphokines | 4 | 2002 | 122 | 0.150 |
Why?
|
Marijuana Smoking | 1 | 2021 | 220 | 0.150 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2018 | 84 | 0.150 |
Why?
|
Respiratory Mucosa | 4 | 2014 | 254 | 0.150 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2017 | 404 | 0.150 |
Why?
|
Myofibroblasts | 1 | 2018 | 120 | 0.150 |
Why?
|
Cell Division | 6 | 2009 | 776 | 0.150 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 77 | 0.150 |
Why?
|
Complement C3 | 1 | 2018 | 192 | 0.150 |
Why?
|
Herpesvirus 4, Human | 1 | 1997 | 126 | 0.150 |
Why?
|
Genes, Viral | 2 | 2009 | 93 | 0.150 |
Why?
|
Mycobacterium Infections, Nontuberculous | 1 | 2021 | 334 | 0.150 |
Why?
|
Genotype | 3 | 2018 | 1882 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2017 | 65 | 0.140 |
Why?
|
Thromboplastin | 2 | 2007 | 68 | 0.140 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 142 | 0.140 |
Why?
|
Smoking | 3 | 2017 | 1487 | 0.140 |
Why?
|
Scleroderma, Systemic | 1 | 1997 | 94 | 0.140 |
Why?
|
Hemangioma, Capillary | 2 | 2006 | 13 | 0.140 |
Why?
|
RNA Stability | 1 | 2017 | 97 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 4 | 2013 | 842 | 0.140 |
Why?
|
Wnt Proteins | 2 | 2015 | 140 | 0.140 |
Why?
|
Cells, Cultured | 9 | 2020 | 4077 | 0.140 |
Why?
|
Autopsy | 1 | 2016 | 89 | 0.140 |
Why?
|
Proteins | 3 | 2015 | 938 | 0.140 |
Why?
|
Receptors, CXCR4 | 2 | 2014 | 81 | 0.140 |
Why?
|
Muscle, Smooth | 4 | 2007 | 157 | 0.140 |
Why?
|
Autoantibodies | 3 | 2019 | 1335 | 0.140 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 455 | 0.130 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2015 | 41 | 0.130 |
Why?
|
Cell Cycle Proteins | 1 | 1999 | 565 | 0.130 |
Why?
|
Rhadinovirus | 1 | 2015 | 16 | 0.130 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 409 | 0.130 |
Why?
|
Cell Proliferation | 10 | 2019 | 2275 | 0.130 |
Why?
|
Computer Simulation | 1 | 1999 | 922 | 0.130 |
Why?
|
Rare Diseases | 3 | 2019 | 113 | 0.130 |
Why?
|
Transcriptome | 4 | 2023 | 756 | 0.130 |
Why?
|
NF-kappa B | 3 | 2014 | 670 | 0.120 |
Why?
|
Nitrofurantoin | 1 | 2014 | 7 | 0.120 |
Why?
|
Bronchopneumonia | 1 | 2014 | 5 | 0.120 |
Why?
|
Trans-Activators | 1 | 2017 | 373 | 0.120 |
Why?
|
Anti-Infective Agents, Urinary | 1 | 2014 | 14 | 0.120 |
Why?
|
Cystitis | 1 | 2014 | 21 | 0.120 |
Why?
|
Glutaredoxins | 1 | 2014 | 12 | 0.120 |
Why?
|
Heterocyclic Compounds | 1 | 2014 | 21 | 0.120 |
Why?
|
Risk Assessment | 3 | 2019 | 3057 | 0.120 |
Why?
|
Airway Remodeling | 2 | 2012 | 57 | 0.120 |
Why?
|
Autoimmunity | 1 | 2020 | 831 | 0.120 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 371 | 0.120 |
Why?
|
Cellular Senescence | 1 | 2015 | 151 | 0.120 |
Why?
|
B-Lymphocytes | 5 | 2012 | 770 | 0.120 |
Why?
|
Virulence Factors | 1 | 2015 | 140 | 0.120 |
Why?
|
CD146 Antigen | 1 | 2013 | 41 | 0.120 |
Why?
|
Tobacco Smoke Pollution | 2 | 2013 | 233 | 0.120 |
Why?
|
RNA, Untranslated | 1 | 2015 | 115 | 0.120 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2013 | 23 | 0.120 |
Why?
|
Transforming Growth Factor beta | 4 | 2020 | 462 | 0.120 |
Why?
|
Cryptogenic Organizing Pneumonia | 3 | 2014 | 17 | 0.110 |
Why?
|
beta Catenin | 1 | 2015 | 219 | 0.110 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 551 | 0.110 |
Why?
|
Collagen | 2 | 2012 | 433 | 0.110 |
Why?
|
Dyspnea | 3 | 2014 | 201 | 0.110 |
Why?
|
Pneumonia, Viral | 1 | 2018 | 348 | 0.110 |
Why?
|
Retrospective Studies | 14 | 2022 | 12978 | 0.110 |
Why?
|
DNA, Viral | 2 | 2005 | 356 | 0.110 |
Why?
|
Lymphatic Vessels | 1 | 2012 | 54 | 0.110 |
Why?
|
Tyrosine | 2 | 2003 | 233 | 0.110 |
Why?
|
Ovalbumin | 1 | 2012 | 165 | 0.110 |
Why?
|
Pseudomonas Infections | 1 | 2014 | 193 | 0.110 |
Why?
|
PTEN Phosphohydrolase | 1 | 2013 | 143 | 0.110 |
Why?
|
Antigens, CD | 5 | 2009 | 460 | 0.110 |
Why?
|
Host-Pathogen Interactions | 1 | 2015 | 300 | 0.100 |
Why?
|
Cilia | 1 | 2013 | 160 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2006 | 709 | 0.100 |
Why?
|
Mice, Inbred C57BL | 8 | 2015 | 4908 | 0.100 |
Why?
|
Interleukins | 1 | 2013 | 242 | 0.100 |
Why?
|
Simian Immunodeficiency Virus | 3 | 2008 | 98 | 0.100 |
Why?
|
Young Adult | 6 | 2020 | 10793 | 0.100 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 2 | 2008 | 20 | 0.100 |
Why?
|
Pulmonary Surfactants | 3 | 2018 | 98 | 0.100 |
Why?
|
Pseudomonas aeruginosa | 1 | 2014 | 305 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 1167 | 0.100 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2017 | 968 | 0.100 |
Why?
|
Disease Progression | 6 | 2013 | 2490 | 0.100 |
Why?
|
Receptors, Growth Factor | 2 | 2002 | 50 | 0.100 |
Why?
|
Arthritis, Rheumatoid | 2 | 2013 | 989 | 0.100 |
Why?
|
Serpins | 2 | 2015 | 26 | 0.100 |
Why?
|
Lymphocytes | 3 | 2009 | 347 | 0.100 |
Why?
|
T-Lymphocytes | 3 | 2009 | 1774 | 0.090 |
Why?
|
Actins | 3 | 2014 | 404 | 0.090 |
Why?
|
Biomarkers | 7 | 2019 | 3588 | 0.090 |
Why?
|
von Willebrand Factor | 3 | 2014 | 58 | 0.090 |
Why?
|
Hypertrophy, Right Ventricular | 3 | 2007 | 146 | 0.090 |
Why?
|
Hemoptysis | 1 | 2010 | 39 | 0.090 |
Why?
|
Immunization | 1 | 2012 | 412 | 0.090 |
Why?
|
Immunoglobulin G | 2 | 2022 | 788 | 0.090 |
Why?
|
HIV Infections | 3 | 2008 | 2459 | 0.090 |
Why?
|
Mycophenolic Acid | 2 | 2020 | 79 | 0.090 |
Why?
|
Salivary Glands, Minor | 1 | 2009 | 6 | 0.090 |
Why?
|
Teratoma | 1 | 2010 | 92 | 0.090 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 21 | 0.090 |
Why?
|
Signal Transduction | 8 | 2020 | 4709 | 0.090 |
Why?
|
Lymphoproliferative Disorders | 1 | 2009 | 46 | 0.090 |
Why?
|
Plasma Cells | 2 | 2009 | 59 | 0.090 |
Why?
|
Sjogren's Syndrome | 1 | 2009 | 40 | 0.090 |
Why?
|
Blotting, Western | 3 | 2010 | 1194 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2002 | 229 | 0.080 |
Why?
|
Proportional Hazards Models | 2 | 2009 | 1125 | 0.080 |
Why?
|
Fatal Outcome | 2 | 2006 | 287 | 0.080 |
Why?
|
Scleroderma, Limited | 1 | 2008 | 3 | 0.080 |
Why?
|
Biopsy, Needle | 2 | 2019 | 190 | 0.080 |
Why?
|
Bronchoalveolar Lavage Fluid | 5 | 2013 | 613 | 0.080 |
Why?
|
Nasal Mucosa | 1 | 2009 | 97 | 0.080 |
Why?
|
Vascular Endothelial Growth Factors | 4 | 2002 | 67 | 0.080 |
Why?
|
Specialization | 1 | 2009 | 120 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 4 | 2017 | 2275 | 0.080 |
Why?
|
Hemodynamics | 3 | 2012 | 1003 | 0.080 |
Why?
|
Neutrophils | 3 | 2009 | 1233 | 0.080 |
Why?
|
Carcinoid Tumor | 1 | 2008 | 25 | 0.080 |
Why?
|
Cyclins | 2 | 2009 | 82 | 0.080 |
Why?
|
Mountaineering | 1 | 2008 | 47 | 0.080 |
Why?
|
Cell Differentiation | 2 | 2007 | 1753 | 0.080 |
Why?
|
Aged, 80 and over | 7 | 2020 | 6561 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2008 | 56 | 0.080 |
Why?
|
Transfection | 4 | 2013 | 888 | 0.080 |
Why?
|
Chemotactic Factors | 1 | 2007 | 51 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2014 | 812 | 0.080 |
Why?
|
Angiogenesis Inhibitors | 2 | 2007 | 219 | 0.080 |
Why?
|
Chemokines, CXC | 1 | 2007 | 64 | 0.080 |
Why?
|
Respiratory Sounds | 1 | 2008 | 119 | 0.080 |
Why?
|
Antigens, CD34 | 1 | 2007 | 98 | 0.080 |
Why?
|
Neurosecretory Systems | 2 | 2004 | 33 | 0.080 |
Why?
|
Antihypertensive Agents | 2 | 2012 | 437 | 0.070 |
Why?
|
Acrolein | 1 | 2007 | 24 | 0.070 |
Why?
|
In Vitro Techniques | 2 | 2006 | 1094 | 0.070 |
Why?
|
Photomicrography | 1 | 2006 | 6 | 0.070 |
Why?
|
Interprofessional Relations | 1 | 2009 | 261 | 0.070 |
Why?
|
Stress, Mechanical | 2 | 2005 | 443 | 0.070 |
Why?
|
Angiomatosis | 1 | 2006 | 4 | 0.070 |
Why?
|
Gene Products, nef | 1 | 2006 | 13 | 0.070 |
Why?
|
Mice, Transgenic | 5 | 2019 | 2025 | 0.070 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2006 | 28 | 0.070 |
Why?
|
Lymphocytosis | 1 | 2006 | 9 | 0.070 |
Why?
|
Adolescent | 12 | 2020 | 18480 | 0.070 |
Why?
|
Arterioles | 1 | 2006 | 46 | 0.070 |
Why?
|
Immune System Diseases | 1 | 2006 | 35 | 0.070 |
Why?
|
Adenoma | 2 | 2004 | 191 | 0.070 |
Why?
|
Time Factors | 4 | 2014 | 6412 | 0.070 |
Why?
|
Leukocyte Common Antigens | 2 | 2014 | 76 | 0.070 |
Why?
|
Simvastatin | 1 | 2006 | 65 | 0.070 |
Why?
|
Virus Replication | 4 | 2009 | 405 | 0.070 |
Why?
|
Receptor, Bradykinin B2 | 1 | 2005 | 2 | 0.070 |
Why?
|
Hemangioma | 1 | 2006 | 41 | 0.070 |
Why?
|
MicroRNAs | 1 | 2012 | 637 | 0.070 |
Why?
|
Bronchography | 1 | 2005 | 10 | 0.070 |
Why?
|
Asthma | 3 | 2021 | 2158 | 0.070 |
Why?
|
Protein Kinase C-epsilon | 1 | 2005 | 31 | 0.070 |
Why?
|
Subacute Sclerosing Panencephalitis | 1 | 2005 | 6 | 0.070 |
Why?
|
Protein Kinase C | 1 | 2007 | 297 | 0.070 |
Why?
|
Calcium Channels, T-Type | 1 | 2005 | 16 | 0.070 |
Why?
|
Capillaries | 1 | 2005 | 103 | 0.070 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2005 | 56 | 0.070 |
Why?
|
Calcineurin Inhibitors | 1 | 2005 | 61 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2005 | 147 | 0.060 |
Why?
|
Vasculitis | 1 | 2005 | 75 | 0.060 |
Why?
|
Cohort Studies | 6 | 2012 | 5116 | 0.060 |
Why?
|
Syndrome | 2 | 2022 | 344 | 0.060 |
Why?
|
Tissue Fixation | 1 | 2004 | 32 | 0.060 |
Why?
|
Protein Kinases | 1 | 2007 | 310 | 0.060 |
Why?
|
Specimen Handling | 1 | 2006 | 165 | 0.060 |
Why?
|
Sepharose | 1 | 2004 | 33 | 0.060 |
Why?
|
Postoperative Complications | 3 | 2022 | 2235 | 0.060 |
Why?
|
Organ Preservation Solutions | 1 | 2004 | 44 | 0.060 |
Why?
|
Pulmonary Ventilation | 1 | 2005 | 71 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 3 | 2014 | 410 | 0.060 |
Why?
|
Growth Hormone-Releasing Hormone | 1 | 2004 | 27 | 0.060 |
Why?
|
Collagen Diseases | 1 | 2004 | 6 | 0.060 |
Why?
|
Lymphoma, B-Cell | 1 | 2005 | 85 | 0.060 |
Why?
|
Organ Preservation | 1 | 2004 | 67 | 0.060 |
Why?
|
Acromegaly | 1 | 2004 | 15 | 0.060 |
Why?
|
Silicates | 1 | 2024 | 11 | 0.060 |
Why?
|
Lipopolysaccharides | 3 | 2018 | 870 | 0.060 |
Why?
|
Chemokine CXCL12 | 2 | 2019 | 80 | 0.060 |
Why?
|
HIV-1 | 2 | 2008 | 776 | 0.060 |
Why?
|
Granuloma | 1 | 2004 | 87 | 0.060 |
Why?
|
Nerve Growth Factors | 1 | 2004 | 74 | 0.060 |
Why?
|
Sirolimus | 1 | 2005 | 195 | 0.060 |
Why?
|
Eye Proteins | 1 | 2004 | 77 | 0.060 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2023 | 31 | 0.060 |
Why?
|
Guanosine | 1 | 2003 | 39 | 0.060 |
Why?
|
Castleman Disease | 1 | 2003 | 14 | 0.060 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2024 | 196 | 0.060 |
Why?
|
Genetic Techniques | 1 | 2004 | 60 | 0.060 |
Why?
|
Caspases | 3 | 2014 | 269 | 0.060 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2004 | 152 | 0.060 |
Why?
|
Bone Morphogenetic Protein Receptors, Type II | 1 | 2003 | 48 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 2 | 2007 | 521 | 0.060 |
Why?
|
Oligopeptides | 1 | 2005 | 252 | 0.060 |
Why?
|
Pneumonectomy | 3 | 2010 | 115 | 0.060 |
Why?
|
Carmustine | 1 | 2003 | 47 | 0.060 |
Why?
|
Precancerous Conditions | 1 | 2004 | 160 | 0.060 |
Why?
|
Transplantation Chimera | 1 | 2003 | 51 | 0.060 |
Why?
|
Siderosis | 1 | 2002 | 3 | 0.060 |
Why?
|
Plague | 1 | 2003 | 42 | 0.060 |
Why?
|
Communication | 1 | 2009 | 761 | 0.060 |
Why?
|
Capillary Permeability | 2 | 2013 | 140 | 0.060 |
Why?
|
Macaca | 3 | 2008 | 54 | 0.060 |
Why?
|
Mutation | 2 | 2023 | 3457 | 0.060 |
Why?
|
Occupations | 1 | 2022 | 37 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 984 | 0.060 |
Why?
|
Sudden Infant Death | 1 | 2002 | 25 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2004 | 287 | 0.050 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2003 | 93 | 0.050 |
Why?
|
Interleukin-6 | 3 | 2014 | 688 | 0.050 |
Why?
|
Clone Cells | 2 | 2020 | 248 | 0.050 |
Why?
|
Biopolymers | 1 | 2022 | 26 | 0.050 |
Why?
|
Cerebrospinal Fluid Leak | 1 | 2022 | 28 | 0.050 |
Why?
|
Skull Base | 1 | 2022 | 44 | 0.050 |
Why?
|
Child | 7 | 2009 | 19129 | 0.050 |
Why?
|
Hyperplasia | 4 | 2004 | 170 | 0.050 |
Why?
|
Chinchilla | 1 | 2022 | 38 | 0.050 |
Why?
|
Blood Coagulation | 1 | 2003 | 219 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 387 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2006 | 527 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2002 | 225 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2005 | 290 | 0.050 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 195 | 0.050 |
Why?
|
Bronchoscopy | 3 | 2010 | 247 | 0.050 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2002 | 112 | 0.050 |
Why?
|
Viral Proteins | 1 | 2003 | 296 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2003 | 1965 | 0.050 |
Why?
|
Vascular Diseases | 1 | 2004 | 241 | 0.050 |
Why?
|
Mycobacterium avium Complex | 1 | 2021 | 93 | 0.050 |
Why?
|
Lung Volume Measurements | 1 | 2001 | 46 | 0.050 |
Why?
|
E-Selectin | 2 | 2015 | 52 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 564 | 0.050 |
Why?
|
United States | 4 | 2023 | 12555 | 0.050 |
Why?
|
Stem Cells | 2 | 2003 | 559 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 3 | 2008 | 165 | 0.050 |
Why?
|
Radiography | 3 | 2012 | 861 | 0.050 |
Why?
|
Brain | 2 | 2005 | 2490 | 0.050 |
Why?
|
Reference Values | 2 | 2018 | 774 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2003 | 755 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2013 | 86 | 0.050 |
Why?
|
Azathioprine | 1 | 2020 | 51 | 0.050 |
Why?
|
Glycoproteins | 1 | 2002 | 319 | 0.050 |
Why?
|
Thrombosis | 1 | 2003 | 309 | 0.050 |
Why?
|
Interleukin-8 | 2 | 2013 | 249 | 0.050 |
Why?
|
Sulfhydryl Compounds | 1 | 2022 | 179 | 0.050 |
Why?
|
Risk Factors | 2 | 2011 | 9000 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2000 | 91 | 0.050 |
Why?
|
Keratin-15 | 1 | 2019 | 14 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2014 | 1293 | 0.050 |
Why?
|
Symptom Assessment | 1 | 2021 | 123 | 0.050 |
Why?
|
Pulmonary Edema | 2 | 2013 | 125 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2018 | 1308 | 0.040 |
Why?
|
Prevalence | 2 | 2022 | 2326 | 0.040 |
Why?
|
Endoscopy | 1 | 2022 | 272 | 0.040 |
Why?
|
Electronic Nicotine Delivery Systems | 1 | 2021 | 81 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2015 | 1206 | 0.040 |
Why?
|
Rituximab | 1 | 2020 | 155 | 0.040 |
Why?
|
Mast Cells | 1 | 2000 | 115 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1999 | 69 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 105 | 0.040 |
Why?
|
Colloids | 1 | 2019 | 60 | 0.040 |
Why?
|
Intramolecular Oxidoreductases | 1 | 1999 | 59 | 0.040 |
Why?
|
Promoter Regions, Genetic | 2 | 2018 | 1158 | 0.040 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2020 | 137 | 0.040 |
Why?
|
Heart Transplantation | 1 | 2005 | 671 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 1868 | 0.040 |
Why?
|
Observer Variation | 2 | 2012 | 309 | 0.040 |
Why?
|
Caspase Inhibitors | 2 | 2012 | 82 | 0.040 |
Why?
|
Mesoderm | 1 | 2020 | 141 | 0.040 |
Why?
|
Weight Loss | 2 | 2014 | 655 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 2851 | 0.040 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1999 | 111 | 0.040 |
Why?
|
Cell Separation | 1 | 2020 | 296 | 0.040 |
Why?
|
CD13 Antigens | 1 | 1998 | 4 | 0.040 |
Why?
|
Child, Preschool | 6 | 2009 | 9491 | 0.040 |
Why?
|
Survival Analysis | 3 | 2009 | 1267 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2013 | 164 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 982 | 0.040 |
Why?
|
Drug Resistance, Microbial | 1 | 2018 | 67 | 0.040 |
Why?
|
Tissue Culture Techniques | 1 | 2018 | 67 | 0.040 |
Why?
|
Prednisone | 1 | 2019 | 235 | 0.040 |
Why?
|
Food Additives | 1 | 2018 | 7 | 0.040 |
Why?
|
Bronchioles | 1 | 2018 | 23 | 0.040 |
Why?
|
Cough | 2 | 2014 | 102 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2002 | 1067 | 0.040 |
Why?
|
A549 Cells | 1 | 2018 | 48 | 0.040 |
Why?
|
Radiography, Thoracic | 2 | 2010 | 164 | 0.040 |
Why?
|
Food Industry | 1 | 2018 | 14 | 0.040 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2013 | 127 | 0.040 |
Why?
|
Neoplasms | 2 | 2009 | 2179 | 0.040 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2019 | 140 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 1999 | 188 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2017 | 2062 | 0.040 |
Why?
|
Cell Lineage | 1 | 2020 | 318 | 0.040 |
Why?
|
Public Health Surveillance | 1 | 2018 | 58 | 0.040 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 1998 | 45 | 0.040 |
Why?
|
In Situ Hybridization | 2 | 2014 | 311 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2019 | 4596 | 0.040 |
Why?
|
Mucin-1 | 1 | 1997 | 18 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 770 | 0.040 |
Why?
|
Epithelial Cells | 3 | 2009 | 963 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2003 | 540 | 0.040 |
Why?
|
Macrophages | 3 | 2013 | 1324 | 0.040 |
Why?
|
ErbB Receptors | 1 | 2001 | 569 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 736 | 0.040 |
Why?
|
Kenya | 1 | 1997 | 100 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2003 | 1178 | 0.040 |
Why?
|
Factor VIII | 1 | 1997 | 56 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2002 | 702 | 0.040 |
Why?
|
Japan | 1 | 2017 | 97 | 0.040 |
Why?
|
Cystic Fibrosis | 2 | 2008 | 964 | 0.040 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1997 | 55 | 0.040 |
Why?
|
CD3 Complex | 1 | 1997 | 92 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 311 | 0.040 |
Why?
|
Rats, Nude | 2 | 2007 | 27 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 1997 | 108 | 0.040 |
Why?
|
Cholesterol | 1 | 2018 | 373 | 0.040 |
Why?
|
Muscle Strength | 1 | 2019 | 283 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 827 | 0.040 |
Why?
|
Biomarkers, Tumor | 2 | 2005 | 1059 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2020 | 1085 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2019 | 9342 | 0.030 |
Why?
|
ADAMTS9 Protein | 1 | 2015 | 5 | 0.030 |
Why?
|
Serpin E2 | 1 | 2015 | 5 | 0.030 |
Why?
|
Procollagen N-Endopeptidase | 1 | 2015 | 7 | 0.030 |
Why?
|
ADAMTS4 Protein | 1 | 2015 | 15 | 0.030 |
Why?
|
Receptor for Advanced Glycation End Products | 1 | 2015 | 34 | 0.030 |
Why?
|
Arteries | 2 | 2010 | 250 | 0.030 |
Why?
|
ADAM Proteins | 1 | 2015 | 59 | 0.030 |
Why?
|
Recovery of Function | 1 | 2019 | 604 | 0.030 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2015 | 18 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 1998 | 502 | 0.030 |
Why?
|
Transcription Factors | 1 | 2003 | 1570 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 1945 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2008 | 828 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2007 | 403 | 0.030 |
Why?
|
Thiocarbamates | 1 | 2014 | 8 | 0.030 |
Why?
|
Iloprost | 1 | 2015 | 46 | 0.030 |
Why?
|
Caspase 3 | 2 | 2006 | 243 | 0.030 |
Why?
|
Hypertension | 1 | 2003 | 1203 | 0.030 |
Why?
|
Prospective Studies | 1 | 2006 | 6471 | 0.030 |
Why?
|
Cannabis | 1 | 2021 | 382 | 0.030 |
Why?
|
Pyrrolidines | 1 | 2014 | 57 | 0.030 |
Why?
|
Benzylamines | 1 | 2014 | 40 | 0.030 |
Why?
|
Endostatins | 1 | 2013 | 11 | 0.030 |
Why?
|
Activins | 1 | 2013 | 26 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2000 | 513 | 0.030 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2014 | 41 | 0.030 |
Why?
|
Epithelium | 2 | 2007 | 305 | 0.030 |
Why?
|
Virulence | 1 | 2015 | 240 | 0.030 |
Why?
|
Integrin alphaVbeta3 | 1 | 2013 | 25 | 0.030 |
Why?
|
Bacterial Load | 1 | 2014 | 61 | 0.030 |
Why?
|
Forced Expiratory Volume | 2 | 2007 | 520 | 0.030 |
Why?
|
Mortality, Premature | 1 | 2013 | 13 | 0.030 |
Why?
|
Nitrogen Oxides | 1 | 2013 | 56 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2018 | 545 | 0.030 |
Why?
|
Carrier Proteins | 1 | 1998 | 726 | 0.030 |
Why?
|
Chemokine CCL5 | 1 | 2013 | 48 | 0.030 |
Why?
|
RNA | 2 | 2013 | 833 | 0.030 |
Why?
|
Gene Deletion | 1 | 2015 | 361 | 0.030 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2013 | 95 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 67 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2012 | 9 | 0.030 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2005 | 198 | 0.030 |
Why?
|
Lymphangiogenesis | 1 | 2012 | 23 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2012 | 16 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 314 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2012 | 55 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 2012 | 66 | 0.030 |
Why?
|
Asparagine | 1 | 2012 | 30 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 298 | 0.030 |
Why?
|
Tobacco Products | 1 | 2013 | 69 | 0.030 |
Why?
|
Glutathione | 1 | 2014 | 324 | 0.030 |
Why?
|
Fatigue | 1 | 2014 | 297 | 0.030 |
Why?
|
Nuclear Proteins | 2 | 2008 | 597 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2013 | 230 | 0.030 |
Why?
|
Cardiomegaly | 1 | 2013 | 168 | 0.030 |
Why?
|
Cell Death | 1 | 2013 | 339 | 0.030 |
Why?
|
Membrane Proteins | 1 | 1998 | 1055 | 0.030 |
Why?
|
RNA Interference | 1 | 2013 | 460 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 369 | 0.020 |
Why?
|
Sex Distribution | 1 | 2012 | 351 | 0.020 |
Why?
|
Survival Rate | 2 | 2007 | 1720 | 0.020 |
Why?
|
Glioblastoma | 1 | 2013 | 262 | 0.020 |
Why?
|
Cytokines | 2 | 2014 | 1900 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 940 | 0.020 |
Why?
|
Phenotype | 2 | 2013 | 3003 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2014 | 1223 | 0.020 |
Why?
|
Dexamethasone | 1 | 2012 | 320 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2012 | 420 | 0.020 |
Why?
|
Chest Pain | 1 | 2010 | 84 | 0.020 |
Why?
|
Cytoplasm | 1 | 2010 | 269 | 0.020 |
Why?
|
Maxillary Sinus | 1 | 2009 | 13 | 0.020 |
Why?
|
Elastin | 1 | 2009 | 77 | 0.020 |
Why?
|
Eisenmenger Complex | 1 | 2008 | 10 | 0.020 |
Why?
|
Peroxidase | 1 | 2009 | 170 | 0.020 |
Why?
|
Myoblasts | 1 | 2009 | 75 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2009 | 146 | 0.020 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2008 | 15 | 0.020 |
Why?
|
Natural Killer T-Cells | 1 | 2009 | 62 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2008 | 153 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2008 | 94 | 0.020 |
Why?
|
Phosphorylation | 1 | 2012 | 1633 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2003 | 1012 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 533 | 0.020 |
Why?
|
Monocrotaline | 1 | 2007 | 35 | 0.020 |
Why?
|
Blood Pressure | 2 | 2005 | 1664 | 0.020 |
Why?
|
Cell Transdifferentiation | 1 | 2007 | 32 | 0.020 |
Why?
|
Infant | 3 | 2009 | 8293 | 0.020 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2007 | 58 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2010 | 580 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2007 | 138 | 0.020 |
Why?
|
Pulmonary Gas Exchange | 1 | 2007 | 117 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2008 | 211 | 0.020 |
Why?
|
Vasoconstriction | 1 | 2008 | 213 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2007 | 204 | 0.020 |
Why?
|
Receptors, Epoprostenol | 1 | 2006 | 6 | 0.020 |
Why?
|
Angiography | 1 | 2007 | 185 | 0.020 |
Why?
|
Vital Capacity | 1 | 2007 | 260 | 0.020 |
Why?
|
Isoenzymes | 1 | 2007 | 297 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2007 | 525 | 0.020 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2005 | 16 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2006 | 112 | 0.020 |
Why?
|
Tunica Intima | 1 | 2005 | 78 | 0.020 |
Why?
|
ADP-ribosyl Cyclase | 1 | 2005 | 4 | 0.020 |
Why?
|
Microdissection | 1 | 2005 | 13 | 0.020 |
Why?
|
Measles virus | 1 | 2005 | 11 | 0.020 |
Why?
|
Cycloheximide | 1 | 2005 | 57 | 0.020 |
Why?
|
Mibefradil | 1 | 2005 | 6 | 0.020 |
Why?
|
ADP-ribosyl Cyclase 1 | 1 | 2005 | 36 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2005 | 41 | 0.020 |
Why?
|
Diltiazem | 1 | 2005 | 22 | 0.020 |
Why?
|
Drug Synergism | 1 | 2006 | 339 | 0.020 |
Why?
|
Shear Strength | 1 | 2005 | 55 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2007 | 656 | 0.020 |
Why?
|
Pleura | 1 | 2004 | 18 | 0.020 |
Why?
|
Glutaral | 1 | 2004 | 15 | 0.020 |
Why?
|
Formaldehyde | 1 | 2004 | 50 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2005 | 173 | 0.020 |
Why?
|
Genome, Viral | 1 | 2005 | 124 | 0.020 |
Why?
|
Lasers | 1 | 2005 | 124 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2005 | 181 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 2005 | 133 | 0.020 |
Why?
|
Immunoblotting | 1 | 2005 | 307 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2005 | 128 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2007 | 356 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2005 | 144 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2004 | 114 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2007 | 306 | 0.020 |
Why?
|
Injections | 1 | 2004 | 167 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2007 | 965 | 0.010 |
Why?
|
Arachidonic Acids | 1 | 2003 | 57 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2005 | 302 | 0.010 |
Why?
|
Blood Circulation | 1 | 2003 | 36 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2007 | 1166 | 0.010 |
Why?
|
CD36 Antigens | 1 | 2003 | 42 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2007 | 442 | 0.010 |
Why?
|
Basement Membrane | 1 | 2003 | 32 | 0.010 |
Why?
|
Anthrax | 1 | 2003 | 9 | 0.010 |
Why?
|
Yersinia pestis | 1 | 2003 | 34 | 0.010 |
Why?
|
Cell Membrane | 1 | 2007 | 710 | 0.010 |
Why?
|
Homeostasis | 1 | 2007 | 594 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2003 | 96 | 0.010 |
Why?
|
Blood | 1 | 2003 | 100 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2007 | 360 | 0.010 |
Why?
|
Forensic Medicine | 1 | 2002 | 16 | 0.010 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2003 | 69 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 446 | 0.010 |
Why?
|
Pituitary Neoplasms | 1 | 2004 | 165 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 896 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2003 | 278 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2005 | 394 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 83 | 0.010 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2002 | 26 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2002 | 63 | 0.010 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2002 | 33 | 0.010 |
Why?
|
Receptors, Interleukin-2 | 1 | 2002 | 65 | 0.010 |
Why?
|
Oxygen | 1 | 2007 | 854 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2003 | 310 | 0.010 |
Why?
|
Graft Rejection | 1 | 2005 | 555 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2003 | 339 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2008 | 1323 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2003 | 181 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2005 | 465 | 0.010 |
Why?
|
Anti-Asthmatic Agents | 1 | 2005 | 343 | 0.010 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2001 | 8 | 0.010 |
Why?
|
Proteolipids | 1 | 2001 | 28 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2006 | 671 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2001 | 124 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2002 | 416 | 0.010 |
Why?
|
Metalloendopeptidases | 1 | 2001 | 56 | 0.010 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2001 | 56 | 0.010 |
Why?
|
Cyanosis | 1 | 2000 | 17 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2003 | 455 | 0.010 |
Why?
|
Polymers | 1 | 2004 | 482 | 0.010 |
Why?
|
Mental Status Schedule | 1 | 2000 | 38 | 0.010 |
Why?
|
Transgenes | 1 | 2001 | 174 | 0.010 |
Why?
|
Th1 Cells | 1 | 2001 | 133 | 0.010 |
Why?
|
Organotechnetium Compounds | 1 | 2000 | 17 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2005 | 892 | 0.010 |
Why?
|
CREST Syndrome | 1 | 1999 | 6 | 0.010 |
Why?
|
Cardiac Catheterization | 1 | 2003 | 541 | 0.010 |
Why?
|
Fever | 1 | 2000 | 283 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2000 | 194 | 0.010 |
Why?
|
Cysteine | 1 | 2000 | 184 | 0.010 |
Why?
|
Cause of Death | 1 | 2000 | 380 | 0.010 |
Why?
|
5-Lipoxygenase-Activating Proteins | 1 | 1998 | 5 | 0.010 |
Why?
|
Hypertrophy | 1 | 1998 | 121 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2000 | 204 | 0.010 |
Why?
|
Acute Disease | 1 | 2000 | 940 | 0.010 |
Why?
|
Recurrence | 1 | 2000 | 975 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2005 | 2874 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2002 | 980 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 1999 | 245 | 0.010 |
Why?
|
Sepsis | 1 | 2003 | 531 | 0.010 |
Why?
|
Altitude | 1 | 2001 | 422 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 1998 | 134 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2000 | 545 | 0.010 |
Why?
|
Aging | 1 | 2006 | 1670 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 1390 | 0.010 |
Why?
|
Age Factors | 1 | 2001 | 2995 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 1999 | 703 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2002 | 5255 | 0.010 |
Why?
|
DNA | 1 | 1998 | 1388 | 0.010 |
Why?
|